BackColoplast A/S Overview

Coloplast A/S Inventory

Latest inventory for CLPBF: $4.1B.

Get informed when a big investor buys or sells

+ Follow
Inventory
$4.13B
↑ 9.38% YoYΔ $354.21M vs prior year quarter

Peer trimmed avg / median

Loading

Coloplast A/S Inventory History

Loading

Coloplast A/S vs. peers: Inventory Comparison

Loading

Coloplast A/S Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Coloplast A/S (CLPBF) FAQ

As of the most recent data (June 2026), CLPBF shows a inventory of $4.1B. That compares with $3.8B in the prior-year period — up 9.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CLPBF's inventory is now $4.1B (was $3.8B) — a 9.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Coloplast A/S is outperforming or lagging.

Tracking CLPBF's inventory over time shows whether Coloplast A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $4.1B That compares with $3.8B in the prior-year period — up 9.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Coloplast A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $4.1B) with ownership activity and broader fundamentals.

Coloplast A/S's inventory is $4.1B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.